SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil.
The Guardant shares were sold for $77 a piece on Wednesday, according to a Friday filing. That’s below the cancer-testing company’s record-high close of $110.30 in August, but still a hefty hike from last year’s $19 initial public offering price. The fund remains Guardant’s largest holder with more than 20 million shares, according to data compiled by Bloomberg.